Tonix Pharmaceuticals
TNXP
$0.17
Share price
5.31%
Change (1 day)
-63.37%
Change (1 year)
Categories
EPS for Tonix Pharmaceuticals (TNXP)
EPS in 2023 (TTM): -$13.74
According to Tonix Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$13.74. In 2022 the company made an earnings per share (EPS) of -$25.52 an increase over its 2021 EPS that were of -$52.06.
EPS history for Tonix Pharmaceuticals from 2008 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$13.74 | -46.14% |
| 2022 | -$25.52 | -50.99% |
| 2021 | -$52.06 | -67.05% |
| 2020 | -$158.00 | -97.43% |
| 2019 | -$6,146 | -87.28% |
| 2018 | -$48,307 | -27.29% |
| 2017 | -$66,442 | -79.07% |
| 2016 | -$317,402 | -42.41% |
| 2015 | -$551,135 | 2.98% |
| 2014 | -$535,179 | -19.56% |
| 2013 | -$665,278 | -40.36% |
| 2012 | -$1,115,518 | -0.49% |
| 2011 | -$1,120,994 | -42.94% |
| 2010 | -$1,964,470 | 6264.1% |
| 2009 | -$30,868 | 46.06% |
| 2008 | -$21,134 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Aerie Pharmaceuticals AERI | -$0.75 | -94.54% | 🇺🇸 USA |
 Eagle Pharmaceuticals
EGRX | $0.92 | -106.69% | 🇺🇸 USA |